The majority of cell death research with direct implications on killing cancer cells has focused on the identification of pathways and therapeutics that promote apoptosis at the levels of pro-apoptotic signaling (Piece #1) and the BCL-2 family (Piece #2). The gene discussed is BCL2; the disease is cancer.